This upregulation was observed irrespective of the mutational landscape of the RET and RAS genes, indicating that epigenetic mechanisms may significantly contribute to the advancement of MTC through pathways distinct from those involving RET and RAS (26). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.